Overcoming resistance to cetuximab with honokiol, a small-molecule polyphenol

Overexpression and activation of the Epidermal Growth Factor Receptor (EGFR) have been linked to poor prognosis in several human cancers. Cetuximab is a monoclonal antibody against EGFR, that is used for the treatment in head and neck squamous cell carcinoma (HNSCC) and metastatic colorectal cancer....

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Mol Cancer Ther
Hoofdauteurs: Pearson, Hannah E., Iida, Mari, Orbuch, Rachel A., McDaniel, Nellie K., Nickel, Kwangok P., Kimple, Randall J., Arbiser, Jack, Wheeler, Deric L.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2017
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5752575/
https://ncbi.nlm.nih.gov/pubmed/29054984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-17-0384
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items